×
For best experience we recommend to activate Javascript in your browser.
Recombinant CD235a/GYPA antibody
The Rabbit Monoclonal anti-CD235a/GYPA antibody (Clone M2A1M2A1) (ABIN7541231) specifically detects CD235a/GYPA in ELISA and IA.
The antibody is reactive with Human samples.
Catalog No. ABIN7541231
$1,347.14
Plus shipping costs $50.00
Delivery in 11 to 14 Business Days
Quick Overview for Recombinant CD235a/GYPA antibody (ABIN7541231)
Target
See all CD235a/GYPA (GYPA) Antibodies
CD235a/GYPA (GYPA)
(Glycophorin A (GYPA))
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for CD235a/GYPA antibodies
Human
Host
All hosts for CD235a/GYPA antibodies
Rabbit
Clonality
All clonalities for CD235a/GYPA antibodies
Monoclonal
Conjugate
All conjugates for CD235a/GYPA antibodies
This CD235a/GYPA antibody is un-conjugated
Application
All applications for CD235a/GYPA antibodies
ELISA, Immunoassay (IA)
Clone
M2A1M2A1
Product Details anti-CD235a/GYPA Antibody
(hide)
Expression System
Mammalian cells
Purpose
Rabbit recombinant monoclonal antibody raised against human GYPA.
Cross-Reactivity
Human
Immunogen
Original antibody is raised against human red blood cells of the M phenotype prepared by immunzing BALB/c mice.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
ELISA,Inhibition Assay,The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
In PBS with 0.02 % Proclin 300
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C. Aliquot to avoid repeated freezing and thawing.
Target Details for CD235a/GYPA
(hide)
Target
CD235a/GYPA (GYPA)
(Glycophorin A (GYPA))
Alternative Name
GYPA
Background
Glycophorin A (MNS blood group)
Gene ID
2993
Pathways
Maintenance of Protein Location
Recently viewed
(hide)
Chat with us , powered by LiveChat